Lutetium177J591QualityChecker

Lutetium-177 J591

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity SPECT
Open selection

Utility description: Lutetium-177 J591

Lutetium-177 J591 Quality Checker — Lutetium-177 J591 (Anti-PSMA mAb) for prostate cancer therapy
ℹ️ Utility checks critical parameters of Lutetium-177 J591:
• Radionuclidic purity (≥99.9%)
• Lutetium-177m impurity (≤0.01%)
• Radiochemical purity (≥95%) — binding to J591 monoclonal antibody
• Free lutetium (≤5%)
• Antibody aggregates (≤5%)
• pH (6.5–7.5), endotoxins, sterility
⚠️ CRITICAL: Aggregates >5% → risk of immunogenicity and rapid clearance from blood!
Free lutetium >5% → accumulation in bone marrow (myelotoxicity)!
Usage:
Lutetium177J591QualityChecker.exe → demo mode (console output)
Lutetium177J591QualityChecker.exe input.csv output.json → evaluate your data
Input format:
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType
Example (sterility: 0=sterile, 1=contaminated):
Lu177-J591-2026-001,3700.0,99.98,0.005,98.5,1.0,1.5,2.0,7.0,30.0,0,Therapeutic
Supported product types:
• Therapeutic — targeted therapy for metastatic castration-resistant prostate cancer (mCRPC)
— WHY IS THIS NEEDED?
Lutetium-177 J591 is a radioimmunoconjugate based on a humanized monoclonal antibody:
• Target: PSMA (Prostate-Specific Membrane Antigen)
• Lu-177 half-life: 6.65 days — optimal for antibody delivery
• Beta radiation destroys prostate tumor cells and bone metastases
• J591 has high affinity for the extracellular domain of PSMA
⚠️ CRITICAL:
• Radiochemical purity ≥95% — Lutetium must be firmly chelated (usually DOTA or DTPA conjugated to the antibody). Free lutetium accumulates in bones.
• Aggregates ≤5% — Aggregated antibodies are rapidly cleared by the reticuloendothelial system (liver/spleen) and can cause anaphylactic reactions. Control by SEC-HPLC is mandatory.
• Lutetium-177m impurity ≤0.01% — Long-lived isomer (T½=160.4 days) creates unnecessary radiation burden.
• pH 6.5–7.5 — Antibodies are sensitive to acidity; deviations lead to denaturation and loss of binding.
Key features:
• Control of aggregates (specific to biologics/antibodies)
• Check for long-lived Lu-177m impurity
• Assessment of free lutetium level (risk of myelotoxicity)
• Narrow pH range for protein stability
Critical parameters:
• Radionuclidic purity: ≥99.9%
• Lutetium-177m impurity: ≤0.01%
• Radiochemical purity: ≥95.0%
• Free lutetium: ≤5.0%
• Aggregates: ≤5.0%
• pH: 6.5–7.5
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
💡 Usage tips:
Radiochemical purity and aggregates are determined by ITLC and SEC-HPLC respectively
Lu-177m is controlled by gamma spectrometry
The drug requires slow intravenous administration to minimize infusion reactions
Specific activity (MBq/mg) is calculated based on total activity and protein concentration
⚠️ Note: Unlike small molecules (peptides), antibodies have a long circulation time in blood (days). This requires high radiochemical purity, as any free isotope will circulate for a long time and irradiate healthy tissues (especially bone marrow). Antibody aggregation is a critical quality parameter absent in small molecules.

input.csv

BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType
Lu177-J591-2026-001,3700.0,99.98,0.005,98.5,1.0,1.5,2.0,7.0,30.0,0,Therapeutic
Lu177-J591-2026-002,3500.0,99.85,0.02,94.0,6.5,6.0,2.1,6.8,180.0,0,Therapeutic
Lu177-J591-2026-003,3800.0,99.99,0.002,99.0,0.5,0.8,1.9,7.2,20.0,0,Therapeutic

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Lutetium177J591QualityChecker for Lutetium-177 J591.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of Lutetium-177 J591:
  • • Radionuclidic purity (≥99.9%)
  • • Lutetium-177m impurity (≤0.01%)
  • • Radiochemical purity (≥95%) — binding to J591 monoclonal antibody
  • • Free lutetium (≤5%)
  • • Antibody aggregates (≤5%)
  • • pH (6.5–7.5), endotoxins, sterility
  • ⚠️ CRITICAL: Aggregates >5% → risk of immunogenicity and rapid clearance from blood!
  • Free lutetium >5% → accumulation in bone marrow (myelotoxicity)!
  • BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType
  • Example (sterility: 0=sterile, 1=contaminated):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥95% — Lutetium must be firmly chelated (usually DOTA or DTPA conjugated to the antibody). Free lutetium accumulates in bones.
  • • Aggregates ≤5% — Aggregated antibodies are rapidly cleared by the reticuloendothelial system (liver/spleen) and can cause anaphylactic reactions. Control by SEC-HPLC is mandatory.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Lutetium-177 J591 using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringLu177-J591-2026-001Batch or lot identifier used for traceability.
2TotalActivityMBqdecimal3700.0Radioactivity value used for release, decay or dose-related assessment.
3RadionuclidicPurityPercentstring99.98Radionuclidic purity; a critical radiation-safety and impurity parameter.
4Lutetium177mImpurityPercentstring0.005Controlled impurity or residual material.
5RadiochemicalPurityPercentstring98.5Radiochemical purity; confirms the labelled chemical form and binding quality.
6FreeLutetiumPercentdecimal1.0Free radionuclide / unbound species; important for non-target uptake and toxicity.
7AggregateContentPercentdecimal1.5Controlled input parameter used by the deterministic QC rules.
8ProteinConcentrationMgPerMldecimal2.0Controlled input parameter used by the deterministic QC rules.
9pHdecimal7.0Solution pH; relevant for stability, compatibility and administration.
10EndotoxinsEUdecimal30.0Bacterial endotoxins; critical for parenteral administration.
11SterilityTestflag / boolean0Sterility result; critical release parameter.
12ProductTypestringTherapeuticControlled input parameter used by the deterministic QC rules.
BatchNumber,TotalActivityMBq,RadionuclidicPurityPercent,Lutetium177mImpurityPercent,RadiochemicalPurityPercent,FreeLutetiumPercent,AggregateContentPercent,ProteinConcentrationMgPerMl,pH,EndotoxinsEU,SterilityTest,ProductType
Lu177-J591-2026-001,3700.0,99.98,0.005,98.5,1.0,1.5,2.0,7.0,30.0,0,Therapeutic
Lu177-J591-2026-002,3500.0,99.85,0.02,94.0,6.5,6.0,2.1,6.8,180.0,0,Therapeutic
Lu177-J591-2026-003,3800.0,99.99,0.002,99.0,0.5,0.8,1.9,7.2,20.0,0,Therapeutic

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Lutetium-177 J591, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "lutetium177-j591-quality-checker",
  "api": "Lutetium-177 J591",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "Lu177-J591-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "TotalActivityMBq",
      "value": "3700.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityPercent",
      "value": "99.98",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "Lutetium177mImpurityPercent",
      "value": "0.005",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeLutetiumPercent",
      "value": "1.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "AggregateContentPercent",
      "value": "1.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "ProteinConcentrationMgPerMl",
      "value": "2.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Andrology QC Suite

QC package for andrology: androgens, erectile-dysfunction medicines, BPH/prostate products, fertility and related hormonal checks.

Open

Biopharmaceuticals Core QC Suite

Focused QC utility package for biologic products: HCP, mAbs, biosimilars, proteins/peptides, sterility, endotoxins and key release checks.

Open

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Immunology QC Suite

QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: beta-emitting therapy

Lu-177, Y-90, Ho-166, Re-188, Sm-153, Sr-89, P-32, Cu-67 and Tb-161.

Open

RPH organ/system: bone and musculoskeletal

Bone scintigraphy, MDP/PYP, marrow, bone-pain palliation, skeletal metastases and radiosynovectomy.

Open

RPH organ/system: hepatobiliary and GI

HIDA, mebrofenin, gallbladder, gastric emptying, GI transit, bleeding and liver/spleen imaging.

Open

RPH organ/system: oncology and theranostics

Tumour imaging, PSMA/FAPI/receptor tracers, immuno-PET, targeted radionuclide therapy and radioembolization.

Open

RPH organ/system: renal and urinary

Renography, GFR/ERPF, renal uptake, DMSA/MAG3/DTPA and bladder-related workflows.

Open

RPH use case: radionuclide therapy and theranostics

Lu-177, Ac-225, Ra-223, Y-90, Ho-166, Sm-153, Sr-89, Re-188, Tb-161, I-131 and other therapeutic radiopharmaceuticals: activity, purity, free metal, daughters and toxicological constraints.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH workflow: stability, storage, decay and waste

Kinetic stability, shelf life, decay correction, expiry, storage, trend and radioactive waste.

Open

RPH workflow: synthesis, labelling and kit reconstitution

Radiolabelling, synthesis, chelation, reducing agent, pH/stoichiometry and kit preparation.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open

Urology QC Suite

QC package for urology: BPH, urolithiasis, overactive bladder, urinary-tract infection medicines and supporting antimicrobial QC checks.

Open